An 8-week, open-label, dose-finding study of Nimodipine for the treatment of progranulin insufficiency from GRN gene mutations
Alzheimer's & Dementia: Translational Research & Clinical Interventions(2016)
摘要
While well tolerated, nimodipine treatment did not alter PGRN concentrations or secondary outcomes.
更多查看译文
关键词
Frontotemporal dementia,Progranulin,Genetics,Nimodipine,Dementia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络